Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
0.324
+0.004 (1.38%)
Nov 20, 2024, 4:00 PM EST - Market closed

Biomerica Revenue

Biomerica had revenue of $1.81M in the quarter ending August 31, 2024, with 5.49% growth. This brings the company's revenue in the last twelve months to $5.51M, up 1.74% year-over-year. In the fiscal year ending May 31, 2024, Biomerica had annual revenue of $5.42M with 1.42% growth.

Revenue (ttm)
$5.51M
Revenue Growth
+1.74%
P/S Ratio
0.99
Revenue / Employee
$86,078
Employees
64
Market Cap
5.46M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 20245.42M76.00K1.42%
May 31, 20235.34M-13.53M-71.71%
May 31, 202218.87M11.67M162.13%
May 31, 20217.20M506.32K7.57%
May 31, 20206.69M1.49M28.69%
May 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro
May 31, 2017 Pro Pro Pro
May 31, 2016 Pro Pro Pro
May 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Applied DNA Sciences 3.40M
Kindly MD 2.88M
Mainz Biomed 917.20K
Mangoceuticals 755.00K
Cyclerion Therapeutics 194.00K
Organovo Holdings 103.00K
Revenue Rankings